P21 (P021)
P021 is a modified peptide derived from an active region of ciliary neurotrophic factor. It is often sold as P21 and sometimes inaccurately described as derived from Cerebrolysin. Product sequence and analytical identity must be verified; no human use is established.
Pharmacokinetic model
A route-level PK model for p21 (p021) is being prepared from published data. Dosing references, studies, and documented interactions are below; the app catalog is updated as models are validated.
Key facts
- Category
- Experimental Peptide
- Suggested cadence
- once daily
Research behind this entry
-
Prevention of dendritic and synaptic deficits and cognitive impairment with a neurotrophic compound
P021 was provided in the diet to triple-transgenic Alzheimer-model mice from 3 to 21 months of age and was associated with selected histologic and behavioral differences. It was not a human study and does not validate…
1 published study referenced in the app, each with a plain-language summary.